MERUS LABS INTERNATIONAL INC. ANNOUNCES ENTRY INTO ADVISORY SERVICES AGREEMENT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

The Canadian National Stock Exchange has not approved nor disapproved the contents of this press release.

(CNSX: MR)

VANCOUVER, April 5 /CNW/ - Merus Labs International Inc. ("Merus" or the "Company") is pleased to announce that it has entered into an advisory services agreement (the "Agreement") with Sandra Broccoli, CA, for the provision of advisory services to the Company's management and board of directors. Ms. Broccoli is currently the Corporate Controller of Liz Claiborne Canada Inc., and the past Director of Corporate Services of Smith & Nephew Inc. in Canada where she led the direction of the Corporate Finance, Contracts & Tenders departments. Smith & Nephew is one of the world's largest wound care management companies with over 9,000 employees and over $3.5 billion in revenue.

During her 11 years of service at Smith & Nephew, Ms. Broccoli established new product launch teams, expedited time to market and empowered the company's National sales team. She was also responsible for contract pricing strategy in collaboration with Sales and Marketing management in line with corporate sales and profit goals. Prior to joining Smith & Nephew, Ms. Broccoli was the tax manager and an auditor at Ernst & Young, LLP for 7 years.

Ms. Broccoli has a graduate degree in Public Accountancy from the University of McGill as well as a Chartered Accountant (CA) designation from the Quebec Order of Chartered Accountants.

About Merus Labs International Inc.

Merus is a specialty pharmaceutical company engaged in the acquisition and licensing of pharmaceutical products. The Company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and United States. Merus further enhances the sale and distribution of these products by introduction of a focused marketing and promotion plan.

Forward-looking Statements:

This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with securities regulatory authorities.

SOURCE Merus Labs International Inc.

For further information:

Dr. Ahmad Doroudian, Chief Executive Officer
Merus Labs International Inc.
Tel: (604) 805-7783
adoroudian@meruslabs.com

Organization Profile

Merus Labs International Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890